Furthermore, several papers showed that GDF-15 may be involved in muscle wasting in a variety of patients including COPD [30], patients undergoing elective high-risk cardiothoracic surgery [31], intensive care unit (ICU) patients [32], and cancer patients [33]. Here, GDF15 is linked to chronic obstructive pulmonary disease.